Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

SELL
$154.79 - $180.76 $118,414 - $138,281
-765 Reduced 8.02%
8,777 $1.51 Million
Q1 2024

Apr 10, 2024

SELL
$159.82 - $182.1 $85,024 - $96,877
-532 Reduced 5.28%
9,542 $1.74 Million
Q4 2023

Jan 12, 2024

SELL
$137.6 - $154.97 $72,790 - $81,979
-529 Reduced 4.99%
10,074 $1.56 Million
Q3 2023

Oct 10, 2023

BUY
$133.59 - $154.65 $109,410 - $126,658
819 Added 8.37%
10,603 $1.58 Million
Q2 2023

Jul 10, 2023

SELL
$132.51 - $164.9 $65,194 - $81,130
-492 Reduced 4.79%
9,784 $1.32 Million
Q1 2023

Apr 11, 2023

SELL
$144.61 - $166.54 $1.39 Million - $1.6 Million
-9,605 Reduced 48.31%
10,276 $1.64 Million
Q4 2022

Jan 11, 2023

BUY
$138.31 - $165.87 $91,699 - $109,971
663 Added 3.45%
19,881 $0
Q3 2022

Oct 11, 2022

BUY
$134.21 - $153.93 $28,318 - $32,479
211 Added 1.11%
19,218 $2.58 Million
Q2 2022

Jul 08, 2022

BUY
$137.62 - $174.96 $23,670 - $30,093
172 Added 0.91%
19,007 $2.91 Million
Q1 2022

Apr 05, 2022

SELL
$131.98 - $163.75 $527 - $655
-4 Reduced 0.02%
18,835 $3.05 Million
Q4 2021

Jan 21, 2022

SELL
$107.43 - $135.93 $843,755 - $1.07 Million
-7,854 Reduced 29.42%
18,839 $2.55 Million
Q3 2021

Oct 06, 2021

SELL
$106.4 - $120.78 $22,237 - $25,243
-209 Reduced 0.78%
26,693 $2.88 Million
Q2 2021

Jul 02, 2021

SELL
$105.21 - $117.21 $68,491 - $76,303
-651 Reduced 2.36%
26,902 $3.03 Million
Q1 2021

Apr 01, 2021

SELL
$102.3 - $112.62 $892,056 - $982,046
-8,720 Reduced 24.04%
27,553 $2.98 Million
Q4 2020

Jan 13, 2021

BUY
$80.49 - $108.67 $93,126 - $125,731
1,157 Added 3.29%
36,273 $3.89 Million
Q3 2020

Oct 02, 2020

BUY
$85.91 - $100.83 $28,865 - $33,878
336 Added 0.97%
35,116 $3.08 Million
Q2 2020

Jul 01, 2020

BUY
$73.37 - $98.18 $92,739 - $124,099
1,264 Added 3.77%
34,780 $3.42 Million
Q4 2019

Jan 02, 2020

BUY
$72.13 - $90.25 $6,635 - $8,303
92 Added 0.28%
33,516 $2.97 Million
Q3 2019

Oct 01, 2019

BUY
$62.98 - $75.72 $15,493 - $18,627
246 Added 0.74%
33,424 $2.53 Million
Q2 2019

Jul 01, 2019

BUY
$65.7 - $83.98 $717,509 - $917,145
10,921 Added 49.07%
33,178 $2.41 Million
Q1 2019

Apr 03, 2019

BUY
$77.14 - $90.79 $56,312 - $66,276
730 Added 3.39%
22,257 $1.79 Million
Q4 2018

Jan 25, 2019

BUY
$77.85 - $96.01 $58,309 - $71,911
749 Added 3.6%
21,527 $1.85 Million
Q3 2018

Oct 29, 2018

BUY
$88.91 - $98.84 $50,767 - $56,437
571 Added 2.83%
20,778 $1.97 Million
Q2 2018

Aug 10, 2018

BUY
$89.78 - $106.23 $1.81 Million - $2.15 Million
20,207 New
20,207 $1.87 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Cox Capital Mgt LLC Portfolio

Follow Cox Capital Mgt LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cox Capital Mgt LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cox Capital Mgt LLC with notifications on news.